CSIMarket
 


Cure Pharmaceutical Holding Corp   (CURR)
Other Ticker:  
 


Cure Pharmaceutical Holding 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



CURR Net Cash Flow Margin (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter

Y / Y Revenue Change - - - - -
Seq. Revenue Change 58.86 % 1.81 % - - -
Revenue In Millions $1.78 $1.12 $1.10 $0.00 $0.00
Net Cash Flow Margin - -42.74 % 46.69 % - -
Net Cash Flow Margin Total Ranking # 234 # # 489 # #
Net Cash Flow In Millions $4.39 $-0.48 $0.52 $0.00 $0.00
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting Third Quarter 2022 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in III. Quarter to 246.19 %, a new company high.

Observing third quarter 2022 results within Major Pharmaceutical Preparations industry 59 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 234.

CURR's Net Cash Flow Margin third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 60
Healthcare Sector # 102
Overall # 234

Net Cash Flow Margin Statistics
High Average Low
246.19 % 146.44 % 46.69 %
(Sep 30 2022)   (Mar 31 2022)




Other Net Cash Flow Margin Profitability Ratios
CURR's Cumulative Net Cash Flow Margin
Major Pharmaceutical Preparations Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
CURR's Net Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for CURR's Competitors
Net Cash Flow Margin Profit Margin for Cure Pharmaceutical Holding 's Suppliers
Net Cash Flow Margin Profit Margin for CURR's Customers

You may also want to know
CURR's Annual Growth Rates CURR's Profitability Ratios CURR's Asset Turnover Ratio CURR's Dividend Growth
CURR's Roe CURR's Valuation Ratios CURR's Financial Strength Ratios CURR's Net Cash Flow Growth
CURR's Roa CURR's Inventory Turnover Ratio CURR's Growth Rates CURR's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Net Cash Flow MarginSep 30 2022 MRQ Net Cash FlowSep 30 2022 MRQ Revenue
Athersys Inc  621.54 %$ 0.404 $ 0.065 
Mirati Therapeutics Inc   612.06 %$ 33.241 $ 5.431 
Hcw Biologics Inc   597.22 %$ 10.804 $ 1.809 
Ngm Biopharmaceuticals Inc   512.26 %$ 40.525 $ 7.911 
Cytokinetics Incorporated  501.27 %$ 12.607 $ 2.515 
Oramed Pharmaceuticals Inc   484.46 %$ 3.304 $ 0.682 
Q Biomed inc   421.22 %$ 0.111 $ 0.026 
Merus N v   412.43 %$ 27.142 $ 6.581 
Evoke Pharma Inc   385.21 %$ 3.205 $ 0.832 
Aadi Bioscience Inc   378.75 %$ 16.078 $ 4.245 
Vbi Vaccines Inc  358.36 %$ 1.136 $ 0.317 
Vaccitech Plc  352.42 %$ 21.727 $ 6.165 
Guardion Health Sciences Inc   327.44 %$ 8.721 $ 2.664 
Rvl Pharmaceuticals Plc  322.68 %$ 32.339 $ 10.022 
Ardelyx inc   291.84 %$ 14.551 $ 4.986 
Pacira Biosciences inc   276.78 %$ 463.517 $ 167.466 
Ensysce Biosciences Inc   275.08 %$ 0.768 $ 0.279 
Mannkind Corporation  270.15 %$ 88.677 $ 32.825 
Ultragenyx Pharmaceutical Inc   257.54 %$ 233.592 $ 90.703 
Jaguar Health inc   255.14 %$ 8.037 $ 3.150 
Aravive Inc   254.06 %$ 12.591 $ 4.956 
Cure Pharmaceutical Holding Corp   246.19 %$ 4.392 $ 1.784 
Endonovo Therapeutics Inc   211.12 %$ 0.023 $ 0.011 
Blueprint Medicines Corporation  205.68 %$ 118.432 $ 57.581 
Agile Therapeutics Inc  203.73 %$ 6.116 $ 3.002 
Esperion Therapeutics Inc   192.09 %$ 36.459 $ 18.980 
Alnylam Pharmaceuticals Inc   188.29 %$ 497.654 $ 264.306 
Evolus Inc   182.22 %$ 61.772 $ 33.899 
Ideaya Biosciences Inc   177.95 %$ 52.848 $ 29.699 
Macrogenics Inc   149.82 %$ 62.524 $ 41.734 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STRM's Profile

Stock Price

STRM's Financials

Business Description

Fundamentals

Charts & Quotes

STRM's News

Suppliers

STRM's Competitors

Customers & Markets

Economic Indicators

STRM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071